Pfizer Balance Sheet Health
Financial Health criteria checks 3/6
Pfizer has a total shareholder equity of $92.6B and total debt of $69.9B, which brings its debt-to-equity ratio to 75.5%. Its total assets and total liabilities are $221.1B and $128.5B respectively. Pfizer's EBIT is $3.1B making its interest coverage ratio 3.6. It has cash and short-term investments of $11.9B.
Key information
75.5%
Debt to equity ratio
US$69.90b
Debt
Interest coverage ratio | 3.6x |
Cash | US$11.93b |
Equity | US$92.56b |
Total liabilities | US$128.54b |
Total assets | US$221.10b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PFED's short term assets ($42.4B) exceed its short term liabilities ($40.5B).
Long Term Liabilities: PFED's short term assets ($42.4B) do not cover its long term liabilities ($88.0B).
Debt to Equity History and Analysis
Debt Level: PFED's net debt to equity ratio (62.6%) is considered high.
Reducing Debt: PFED's debt to equity ratio has reduced from 76.6% to 75.5% over the past 5 years.
Debt Coverage: PFED's debt is not well covered by operating cash flow (12.3%).
Interest Coverage: PFED's interest payments on its debt are well covered by EBIT (3.6x coverage).